- Home
- JFU vs CPIX Comparison
JFU vs CPIX Comparison
Compare JFU & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JFU
- CPIX
- Stock Information
- Founded
- JFU 2006
- CPIX 1999
- Country
- JFU China
- CPIX United States
- Employees
- JFU N/A
- CPIX N/A
- Industry
- JFU Finance: Consumer Services
- CPIX Biotechnology: Pharmaceutical Preparations
- Sector
- JFU Finance
- CPIX Health Care
- Exchange
- JFU Nasdaq
- CPIX Nasdaq
- Market Cap
- JFU 17.9M
- CPIX 17.2M
- IPO Year
- JFU 2019
- CPIX 2009
- Fundamental
- Price
- JFU $1.50
- CPIX $2.27
- Analyst Decision
- JFU
- CPIX
- Analyst Count
- JFU 0
- CPIX 0
- Target Price
- JFU N/A
- CPIX N/A
- AVG Volume (30 Days)
- JFU 11.6K
- CPIX 5.6M
- Earning Date
- JFU 01-03-2025
- CPIX 11-07-2024
- Dividend Yield
- JFU N/A
- CPIX N/A
- EPS Growth
- JFU N/A
- CPIX N/A
- EPS
- JFU 0.09
- CPIX N/A
- Revenue
- JFU $40,614,155.00
- CPIX $36,785,442.00
- Revenue This Year
- JFU N/A
- CPIX N/A
- Revenue Next Year
- JFU N/A
- CPIX N/A
- P/E Ratio
- JFU $16.09
- CPIX N/A
- Revenue Growth
- JFU N/A
- CPIX N/A
- 52 Week Low
- JFU $1.13
- CPIX $1.04
- 52 Week High
- JFU $3.85
- CPIX $3.05
- Technical
- Relative Strength Index (RSI)
- JFU 48.81
- CPIX 67.09
- Support Level
- JFU $1.46
- CPIX $2.07
- Resistance Level
- JFU $1.60
- CPIX $2.43
- Average True Range (ATR)
- JFU 0.11
- CPIX 0.28
- MACD
- JFU 0.01
- CPIX 0.06
- Stochastic Oscillator
- JFU 47.22
- CPIX 60.20
About JFU 9F Inc.
9F Inc is a financial account platform integrating and personalizing financial services in China. It provides a range of financial products and services across online lending, wealth management, and payment facilitation, all integrated under a single digital financial account. The company generates the majority of its revenue from Loan facilitation services. All its revenues are generated from the People's Republic of China.
About CPIX Cumberland Pharmaceuticals Inc.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's primary target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.